Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$40.23
-1.7%
$41.84
$31.01
$50.21
$20.43B0.623.64 million shs3.57 million shs
Cerner Co. stock logo
CERN
Cerner
$94.92
$94.92
$69.08
$95.40
$27.92B0.774.00 million shs1,320 shs
Haleon plc stock logo
HLN
Haleon
$8.40
+0.5%
$8.32
$7.70
$8.99
$38.33B0.295.43 million shs2.27 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$489.24
-1.0%
$532.15
$372.50
$583.39
$40.63B1.26430,629 shs358,456 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-1.71%+1.48%-3.13%+3.71%-12.70%
Cerner Co. stock logo
CERN
Cerner
0.00%0.00%0.00%0.00%0.00%
Haleon plc stock logo
HLN
Haleon
+0.60%+3.39%-0.18%+2.75%-5.57%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-1.02%+2.40%-7.79%-6.81%+1.62%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.7658 of 5 stars
3.13.02.54.02.51.72.5
Cerner Co. stock logo
CERN
Cerner
2.645 of 5 stars
0.00.02.53.90.61.72.5
Haleon plc stock logo
HLN
Haleon
2.634 of 5 stars
0.04.02.50.02.10.02.5
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
4.2949 of 5 stars
2.33.00.03.72.92.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.22
Hold$46.3015.09% Upside
Cerner Co. stock logo
CERN
Cerner
N/AN/AN/AN/A
Haleon plc stock logo
HLN
Haleon
2.60
Moderate BuyN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.67
Moderate Buy$591.5020.90% Upside

Current Analyst Ratings

Latest IDXX, CERN, BAX, and HLN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2024
Haleon plc stock logo
HLN
Haleon
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
4/9/2024
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/3/2024
Baxter International Inc. stock logo
BAX
Baxter International
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$41.00 ➝ $44.00
3/26/2024
Haleon plc stock logo
HLN
Haleon
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/5/2024
Baxter International Inc. stock logo
BAX
Baxter International
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$42.00 ➝ $45.00
2/12/2024
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$52.00 ➝ $54.00
2/9/2024
Baxter International Inc. stock logo
BAX
Baxter International
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$38.00 ➝ $44.00
2/6/2024
Baxter International Inc. stock logo
BAX
Baxter International
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$40.00 ➝ $36.00
2/6/2024
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$600.00 ➝ $630.00
2/6/2024
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$605.00 ➝ $655.00
1/30/2024
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$525.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$14.81B1.38$5.14 per share7.82$16.69 per share2.41
Cerner Co. stock logo
CERN
Cerner
$5.76B4.84$5.37 per share17.69$12.56 per share7.56
Haleon plc stock logo
HLN
Haleon
$14.05B2.73$0.37 per share22.99$4.51 per share1.86
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.66B11.10$11.45 per share42.72$17.88 per share27.36

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
$2.66B$5.227.7112.572.2117.77%19.49%4.77%5/2/2024 (Confirmed)
Cerner Co. stock logo
CERN
Cerner
$555.60M$1.9947.7027.432.3710.15%22.86%11.75%N/A
Haleon plc stock logo
HLN
Haleon
$1.30B$0.2829.9816.462.209.28%12.55%6.13%5/1/2024 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$845.04M$10.0748.5838.313.8023.08%71.66%28.11%5/1/2024 (Confirmed)

Latest IDXX, CERN, BAX, and HLN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Baxter International Inc. stock logo
BAX
Baxter International
$0.61N/A-$0.61N/AN/AN/A  
5/1/2024N/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$2.68N/A-$2.68N/AN/AN/A  
2/8/2024Q4 2023
Baxter International Inc. stock logo
BAX
Baxter International
$0.86$0.88+$0.02$1.28$3.81 billion$3.89 billion    
2/5/202412/31/2023
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$2.12$2.32+$0.20$2.32$891.88 million$901.60 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$1.162.88%+6.70%22.22%N/A
Cerner Co. stock logo
CERN
Cerner
$1.081.14%N/A54.27%N/A
Haleon plc stock logo
HLN
Haleon
$0.212.50%N/A75.00%N/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A

Latest IDXX, CERN, BAX, and HLN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/29/2024
Haleon plc stock logo
HLN
Haleon
semi-annual$0.10641.8%3/14/20243/15/20245/16/2024
2/12/2024
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.292.88%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.48
1.04
Cerner Co. stock logo
CERN
Cerner
0.41
1.79
1.77
Haleon plc stock logo
HLN
Haleon
0.53
1.04
0.73
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.42
1.57
1.17

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Cerner Co. stock logo
CERN
Cerner
82.23%
Haleon plc stock logo
HLN
Haleon
6.67%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.21%
Cerner Co. stock logo
CERN
Cerner
0.12%
Haleon plc stock logo
HLN
Haleon
N/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.11%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000507.83 million506.76 millionOptionable
Cerner Co. stock logo
CERN
Cerner
25,150294.10 million293.75 millionOptionable
Haleon plc stock logo
HLN
Haleon
25,4084.57 billionN/ANot Optionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00083.05 million81.30 millionOptionable

IDXX, CERN, BAX, and HLN Headlines

SourceHeadline
Bank Julius Baer & Co. Ltd Zurich Increases Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Bank Julius Baer & Co. Ltd Zurich Increases Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 25 at 8:21 PM
Illinois Municipal Retirement Fund Has $6.11 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Illinois Municipal Retirement Fund Has $6.11 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 24 at 9:08 AM
IDEXX Laboratories (IDXX) Scheduled to Post Quarterly Earnings on WednesdayIDEXX Laboratories (IDXX) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - April 24 at 2:20 AM
Stock Yards Bank & Trust Co. Increases Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Stock Yards Bank & Trust Co. Increases Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 23 at 9:14 AM
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MAIDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA
marketbeat.com - April 22 at 11:39 PM
Ardevora Asset Management LLP Sells 12,011 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)Ardevora Asset Management LLP Sells 12,011 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 21 at 9:25 PM
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Holdings Raised by abrdn plcIDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Holdings Raised by abrdn plc
marketbeat.com - April 20 at 12:11 PM
RIA Advisory Group LLC Purchases 35,841 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)RIA Advisory Group LLC Purchases 35,841 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 19 at 5:21 PM
What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?
zacks.com - April 19 at 9:01 AM
Ninety One North America Inc. Has $6.60 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Ninety One North America Inc. Has $6.60 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 18 at 1:33 PM
TMO vs. IDXX: Which Stock Is the Better Value Option?TMO vs. IDXX: Which Stock Is the Better Value Option?
zacks.com - April 18 at 12:41 PM
Commit To Buy Idexx Laboratories At $320, Earn 1.4% Annualized Using OptionsCommit To Buy Idexx Laboratories At $320, Earn 1.4% Annualized Using Options
nasdaq.com - April 18 at 10:29 AM
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from BrokeragesIDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - April 18 at 2:34 AM
Validea Detailed Fundamental Analysis - IDXXValidea Detailed Fundamental Analysis - IDXX
nasdaq.com - April 17 at 1:26 AM
Louisiana State Employees Retirement System Makes New $6.44 Million Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Louisiana State Employees Retirement System Makes New $6.44 Million Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 14 at 10:45 AM
New AI Bot Predicts These 7 Stocks Will Mint MillionairesNew AI Bot Predicts These 7 Stocks Will Mint Millionaires
investorplace.com - April 12 at 1:53 PM
19,166 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Purchased by Sapient Capital LLC19,166 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Purchased by Sapient Capital LLC
marketbeat.com - April 11 at 2:05 PM
Idexx Laboratories (IDXX) Beats Stock Market Upswing: What Investors Need to KnowIdexx Laboratories (IDXX) Beats Stock Market Upswing: What Investors Need to Know
zacks.com - April 9 at 7:06 PM
All You Need to Know About Idexx (IDXX) Rating Upgrade to BuyAll You Need to Know About Idexx (IDXX) Rating Upgrade to Buy
zacks.com - April 9 at 1:01 PM
IDEXX Laboratories (NASDAQ:IDXX) Given "Outperform" Rating at William BlairIDEXX Laboratories (NASDAQ:IDXX) Given "Outperform" Rating at William Blair
marketbeat.com - April 9 at 11:21 AM
US close: Stocks mixed as traders await inflation data, Q1 earningsUS close: Stocks mixed as traders await inflation data, Q1 earnings
sharecast.com - April 8 at 10:31 PM
Nisa Investment Advisors LLC Acquires 2,701 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)Nisa Investment Advisors LLC Acquires 2,701 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 8 at 7:46 AM
IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)
seekingalpha.com - April 8 at 7:29 AM
Mirae Asset Global Investments Co. Ltd. Reduces Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Mirae Asset Global Investments Co. Ltd. Reduces Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
marketbeat.com - April 7 at 12:24 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Baxter International logo

Baxter International

NYSE:BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Cerner logo

Cerner

NASDAQ:CERN
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.
Haleon logo

Haleon

NYSE:HLN
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
IDEXX Laboratories logo

IDEXX Laboratories

NASDAQ:IDXX
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.